Lv31
270 积分 2021-05-30 加入
Tirzepatide Once Weekly for the Treatment of Obesity
7天前
已完结
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
7天前
已完结
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
7天前
已完结
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
7天前
已完结
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
7天前
已完结
1626-P: Liver-Specific Silencing of INHBE with ARO-INHBE, an siRNA Therapeutic, for Metabolic Diseases
7天前
已完结
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
7天前
已完结
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
7天前
已完结
Long-Term Persistence of Hormonal Adaptations to Weight Loss
7天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
7天前
已完结
皖公网安备34019202002308
